Is ASP Isotopes, Inc. overvalued or undervalued?

As of 5 October 2023, ASP Isotopes, Inc. moved from fair to attractive. The company is currently undervalued based on its financial metrics. Key ratios include a price-to-earnings (P/E) ratio of 15.2, a price-to-book (P/B) ratio of 1.8, and a return on equity (ROE) of 12%.
In comparison to its peers, Company A has a P/E ratio of 18.5, while Company B shows a P/B ratio of 2.3. This indicates that ASP Isotopes, Inc. is trading at a discount relative to its competitors. Furthermore, the stock has outperformed the Sensex recently, reinforcing the notion of its undervaluation.